semaglutide flow study reduces cardiovascular events in type 2 diabetes: a systematic review and meta-analysis highlighting enhanced benefits in chronic kidney disease | European Journal of Medical Research ADA 24: FLOW Trial: Kidney

Pathway enrichment was evaluated using the MannWhitney U test on gene-level log fold changes in Python, followed by BenjaminiHochberg correction

Glutathione is generally safe but may cause allergic reactions, gastrointestinal issues, and medication interactions

Assessing potential eye health risk from GLP-1 medications The Potential Risks of GLP-1 Agonists and Semaglutide to Eye Health In recent years, GLP-1 agonists, such as semaglutide (commonly marketed under names like Ozempic and Wegovy), have gained widespread popularity for their ability to help with weight loss and manage type 2 diabetes

doi: 10.1096/fj.201700597R 68

Infused with L-Carnitine supports energy production and fat metabolism